Data derived from most recent annual or quarterly report
Market Cap	57.633 Million	Shares Outstanding	112.127 Million	Avg 30-day Volume	1.04 Million
P/E Ratio	0.0	Dividend Yield	0.0	EPS
Price to Revenue	16.1877	Debt to Equity	0.1558	EBITDA	-35.68 Million
Price to Book Value	5.3669	Operating Margin	-498.7654	Enterprise Value	93.23 Million
Current Ratio	4.854	EPS Growth	0	Quick Ratio	4.56
1 Yr BETA	1.7469	52-week High/Low	5.96 / 0.32	Profit Margin	-485.6429
Operating Cash Flow Growth	-95.9789	Altman Z-Score	-16.8314	Free Cash Flow to Firm	-25.759 Million
Earnings Report	2022-08-11

Funds Holding AWH (via 13F filings)

Quarter to view: Refresh Download CSV Download Excel (.xlsx) Download TSV

Market Value:

Ranking:

% of portfolio

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AWH BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

4: filed on 2022-06-01 by SANDFORD NICOLE

4: filed on 2022-05-18 by PALMIERI VALERIE BARBER

4: filed on 2022-05-17 by SANDFORD NICOLE

4: filed on 2022-05-03 by SANDFORD NICOLE

4: filed on 2022-04-04 by JORDAN VERONICA GH

4: filed on 2022-04-04 by FRALICK CELESTE RACHELLE

4: filed on 2022-04-04 by LAFRANCE JAMES T

4: filed on 2022-04-04 by SANDFORD NICOLE

4: filed on 2022-04-04 by BEECHEY ROBERT HARRY

Events (8k)

8-K: filed on 2022-06-07:

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2022-06-02:

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

8-K: filed on 2022-05-18:

Item 7.01: Regulation FD Disclosure

8-K: filed on 2022-05-11:

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2022-03-23:

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2022-02-28:

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2022-01-05:

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

8-K: filed on 2021-11-04:

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

8-K: filed on 2021-06-23:

Item 5.07: Submission of Matters to a Vote of Security Holders

8-K: filed on 2021-05-13:

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Proxy

Prospectus

All

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

142 Thousand total shares from 2 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name	Type	Last Reported Shares Held	Last Reported Date	Filings in past year
SANDFORD NICOLE PRESIDENT AND CEO	Officer Director	5,000	2022-06-01	6
PALMIERI VALERIE BARBER EXECUTIVE CHAIR	Officer Director	267,088	2022-05-16	1
LAFRANCE JAMES T	Director	606,434	2022-03-31	1
JORDAN VERONICA GH	Director	455,152	2022-03-31	1
BEECHEY ROBERT HARRY CHIEF FINANCIAL OFFICER	Officer	150,000	2022-03-31	1
FRALICK CELESTE RACHELLE	Director	99,671	2022-03-31	2
COCOZZA NANCY G	Director	128,632	2021-03-19	0
SCHREIBER DAVID	Director	171,521	2021-03-19	0
BROOKS SANDRA ELAINE	Director	14,728	2021-03-19	0
FEINBERG LARRY N ORACLE PARTNERS LP	SHAREHOLDERSHAREHOLDER	No longer subject to file	2020-07-09	0
SCHULER JACK W		25,394,517	2020-07-01	0
BURNS JAMES S	Director	473,461	2020-06-05	0
SCHULER HENRI GEORGE		14,494,639	2019-06-28	0
PALMIERI VALERIE BARBER PRESIDENT AND CEO PALMIERI VALERIE BARBER PRESIDENT AND CEO	Officer Director	0	2019-03-26	1
SEVERINGHAUS CARL	Director	282,296	2018-04-13	0
FERRARA FRED CHIEF OPERATING OFFICER	Officer	0	2018-04-13	0
FEINBERG LARRY N ORACLE PARTNERS LP ORACLE TEN FUND MASTER, LP ORACLE INSTITUTIONAL PARTNERS L P ORACLE ASSOCIATES LLC ORACLE INVESTMENT MANAGEMENT INC	10% Owner * SEE REMARKS* SEE REMARKS* SEE REMARKS* SEE REMARKS* SEE REMARKS* SEE REMARKS	9,825,289	2017-08-31	0
SCHOEN ERIC SVP FINANCE & CAO	Officer	0	2017-03-23	0
RODDY PETER S	Director	195,555	2016-03-17	0
MUNROE DONALD G SVP BUSINESS DEVELOPMENT & CSO	Officer	0	2016-03-17	0
BRADLEY THOMAS A EVP & CFO	Officer	8,050	2016-02-10	0
WEINHOFF SAMUEL J	Director	41,825	2016-02-08	0
DUPONT WESLEY D EVP & GENERAL COUNSEL	Officer	203,488	2016-02-08	0
CARMILANI SCOTT A PRESIDENT, CEO AND CHAIRMAN	Officer Director	1,353,422	2016-02-08	0
GAUTHIER JOHN J EVP & CIO	Officer	66,152	2016-02-08	0
BAUZON HOLLY B VP MANAGED MARKETS	Officer	0	2015-07-06	0
MILLER LAURA ANN SVP SALES & CUST EXPERIENCE	Officer	0	2015-02-13	0
GOGGIN ROBERT ST LEGER	Director	283,289	2014-12-19	0
MCLAIN THOMAS H PRESIDENT & CEO	Officer	0	2014-03-27	0
SACCO MARIAN E SVP SALES & MARKETING AND CCO	Officer	0	2014-03-27	0
VARMA ERIC	Director	23,000	2014-03-27	0
FEINBERG LARRY N ORACLE PARTNERS LP ORACLE TEN FUND MASTER, LP ORACLE ASSOCIATES LLC ORACLE INVESTMENT MANAGEMENT INC	10% Owner SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS	7,139,960	2013-12-19	0
HUEBNER BRUCE A	FORMER DIRECTOR	No longer subject to file	2013-12-12	0
WALLEN WILLIAM C	FORMER DIRECTOR	No longer subject to file	2013-12-12	0
CREECH WILLIAM B. VP, SALES AND MARKETING	Officer	30,137	2013-11-20	0
SCHWARTZ ERIC S	Director	35,158	2013-11-06	0
DE SAINT-AIGNAN PATRICK	Director	7,820	2013-05-24	0
HAMILTON JOHN F	FORMER DIRECTOR	No longer subject to file	2013-03-21	0
PAGE GAIL S CHIEF EXECUTIVE OFFICER	Officer Director	0	2012-03-22	0
KOHLI ASHISH VP OF CORPORATE STRATEGY	Officer	13,500	2011-09-15	0
FUNG ERIC T S.V.P & C.S.O	Officer	52,471	2011-06-09	0
GARDINER SANDRA VP & CHIEF FINANCIAL OFFICER	Officer	24,000	2011-03-18	0
TRAN JOHN H. VP, FINANCE & CAO	Officer	0	2010-03-19	0
SENNOTT JOHN LANGTON JR EVP, CHIEF CORP. STRAT OFFICER	Officer	13,452	2009-11-19	0
ALEXANDER STILES BARBARA	Director	2,000	2009-08-24	0
RATHMANN JAMES L	Director	0	2008-10-28	0
YOUNG JOHN A	Director	0	2008-10-28	0
DALAL RAJEN	Director	0	2008-10-28	0
CONWAY KENNETH J	Director	0	2008-10-28	0
PHRONESIS PARTNERS L P WIGGINS JAMES	10% Owner	982,222	2008-08-26	0
TAYLOR RICHARD G INTERIM CFO	Officer	0	2008-08-26	0
ZHOU QUN INTERIM CFO	Officer	0	2008-07-18	0
SHORTER SIMON C. VP, CORP BUSINESS DEVELOPMENT	Officer	0	2008-07-18	0
BRUNER JUDY	Director	35,500	2007-09-13	0
CALLAGHAN MICHAEL J	Director	30,500	2007-09-13	0
LUNDY STEVE SENIORVP-SALES & MKTG	Officer	0	2007-05-16	0
SULLIVAN WILLIAM C VP-CORPORATE OPERATIONS	Officer	277,500	2007-04-26	0
YOUNG DEBRA A VP-FINANCE & CFO	Officer	225,000	2007-04-26	0
DILLARD JOAN H SVP & CFO	Officer	35,333	2007-02-26	0
JODOIN RICHARD E PRES, AWAC(US)&NEWMARKETUND.	Officer	22,334	2007-02-15	0
MERRYWEATHER JAMES P EVP, SALES & MARKETING	Officer	100,000	2006-06-07	0

Insider Transactions Last 60 Days

Reporting Owners	Filing Date	Trans Date	Trans Code	Shares	Share Price	Acquired Disposed	Shares Owned after	D/I	Perf 1d*	Perf 5d*	Max Gain	Max Gain Days	Max Loss	Max Loss Days
SANDFORD NICOLE - Director - Officer PRESIDENT AND CEO	2022-06-01 17:26:04 -0400	2022-06-01	A	5,000		a	5,000	direct
SANDFORD NICOLE - Director - Officer PRESIDENT AND CEO	2022-05-17 17:02:01 -0400	2022-05-16	P	98,000	$0.76	a	136,160	direct	-5.1724	-27.5862	0.0	1	-27.5862	6
PALMIERI VALERIE BARBER - Director - Officer EXECUTIVE CHAIR	2022-05-18 09:22:05 -0400	2022-05-16	P	43,994	$0.57	a	267,088	direct	-5.1724	-27.5862	0.0	1	-27.5862	6
SANDFORD NICOLE - Director - Officer PRESIDENT AND CEO	2022-05-03 16:37:20 -0400	2022-05-02	A	5,000		a	5,000	direct

* -

Transaction Code Definitions
Code	Definition
A	Grant, award or other acquisition pursuant to Rule 16b-3(d)
C	Conversion of derivative security
D	Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E	Expiration of short derivative position
F	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G	Bona fide gift
H	Expiration (or cancellation) of long derivative position with value received
I	Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J	Other acquisition or disposition
L	Small acquisition under Rule 16a-6
M	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O	Exercise of out-of-the-money derivative security
P	Open market or private purchase of non-derivative or derivative security
S	Open market or private sale of non-derivative or derivative security
U	Disposition pursuant to a tender of shares in a change of control transaction
W	Acquisition or disposition by will or the laws of descent and distribution
X	Exercise of in-the-money or at-the-money derivative security
Z	Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security	Date/Time	Rebate Rate	Fee Rate	Shares Available
ASPIRA WOMEN'S HEALTH INC AWH	2022-06-23 22:15:03 UTC	-18.5833	20.1533	15000
ASPIRA WOMEN'S HEALTH INC AWH	2022-06-23 21:45:03 UTC	-18.5833	20.1533	15000
ASPIRA WOMEN'S HEALTH INC AWH	2022-06-23 21:15:04 UTC	-18.5833	20.1533	15000
ASPIRA WOMEN'S HEALTH INC AWH	2022-06-23 20:45:03 UTC	-18.5833	20.1533	15000
ASPIRA WOMEN'S HEALTH INC AWH	2022-06-23 20:15:03 UTC	-18.5833	20.1533	15000
ASPIRA WOMEN'S HEALTH INC AWH	2022-06-23 19:45:03 UTC	-18.5833	20.1533	15000
ASPIRA WOMEN'S HEALTH INC AWH	2022-06-23 19:15:03 UTC	-18.5833	20.1533	15000
ASPIRA WOMEN'S HEALTH INC AWH	2022-06-23 18:45:03 UTC	-18.5833	20.1533	15000
ASPIRA WOMEN'S HEALTH INC AWH	2022-06-23 18:15:04 UTC	-18.5833	20.1533	15000
ASPIRA WOMEN'S HEALTH INC AWH	2022-06-23 17:45:04 UTC	-18.5833	20.1533	15000
ASPIRA WOMEN'S HEALTH INC AWH	2022-06-23 17:15:03 UTC	-18.5833	20.1533	15000
ASPIRA WOMEN'S HEALTH INC AWH	2022-06-23 16:45:03 UTC	-18.5833	20.1533	15000
ASPIRA WOMEN'S HEALTH INC AWH	2022-06-23 16:15:03 UTC	-18.5833	20.1533	15000
ASPIRA WOMEN'S HEALTH INC AWH	2022-06-23 15:45:03 UTC	-18.5833	20.1533	15000
ASPIRA WOMEN'S HEALTH INC AWH	2022-06-23 15:15:03 UTC	-18.5833	20.1533	15000
ASPIRA WOMEN'S HEALTH INC AWH	2022-06-22 22:15:03 UTC	-18.7876	20.3576	50000
ASPIRA WOMEN'S HEALTH INC AWH	2022-06-22 21:45:03 UTC	-18.7056	20.2756	50000
ASPIRA WOMEN'S HEALTH INC AWH	2022-06-22 21:15:03 UTC	-18.7056	20.2756	50000
ASPIRA WOMEN'S HEALTH INC AWH	2022-06-22 20:45:03 UTC	-19.2924	20.8624	50000
ASPIRA WOMEN'S HEALTH INC AWH	2022-06-22 20:15:03 UTC	-19.2924	20.8624	50000

Current Active Short Positions

Holder	Issuer	Net Short Position	Position Date	Origin
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund	AWH	-27154.0 shares, $-32856.34	2022-01-31	N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund	AWH	-8899.0 shares, $-9254.96	2022-03-31	N-PORT

Aspira Womens Health Inc YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Aspira Womens Health Inc (AWH)

Funds Holding AWH (via 13F filings)

Filter by:

Mutual Funds Holding AWH BETA

Active Schedule 13D and 13G filings

Recent Filings

Financial Reporting

Ownership

Events (8k)

Proxy

Prospectus

All

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

Open Market Sells (S)

Exercise Derivative Conversion (M)

Current/Former Insiders

Insider Transactions Last 60 Days

IBR Securities Loan Availability

Current Active Short Positions

Elevate your investments